Home > Analytics > ERIS LIFESCIENCES

ERIS LIFESCIENCES
Intrinsic Value | Fundamental Analysis

BOM : 540596     NSE : ERIS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
May 22,2024
Price(EOD): ₹ 908.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 12,350.84 Cr
Value of ₹ 1 Lac invested in ERIS LIFESCIENCES
on May 22,2019 (price: ₹ 568.75)

₹ 1 L

₹ 1.60 L

1W : 3.1% 1M : 2.8% 1Y : 43.8%
COMMUNITY POLL
for ERIS LIFESCIENCES
Please provide your vote to see the results
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
ERIS LIFESCIENCES 3.1% 2.8% 43.8%
SUN PHARMACEUTICAL INDUSTRIES 0.3% 0.1% 65.8%
CIPLA 4.3% 9.4% 57.8%
DR REDDYS LABORATORIES 0.6% -2.4% 30.8%
ZYDUS LIFESCIENCES 6.7% 12.2% 114.6%
DIVIS LABORATORIES 3.3% 8.7% 27.3%
MANKIND PHARMA 0.7% -9.9% 53.7%
TORRENT PHARMACEUTICALS -1.3% 3% 62.6%
LUPIN 3% 6.6% 116.1%

FUNDAMENTAL ANALYSIS OF ERIS LIFESCIENCES

 
Fundamentals Score
[ Q(TTM): Mar2024, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 ERIS is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF ERIS LIFESCIENCES

 
Valuation Score
[As on : May 22,2024 ]

Ratio Consolidated
P/E
P/B
P/S
31.12
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 397.05 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

4.78
P/B Calculated based on Book Value of Rs 2,586.12 Cr
[Latest Year - Mar2024 - Consolidated Results ]

6.15
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,009.14 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF ERIS LIFESCIENCES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
48%
-12%
-19%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF ERIS LIFESCIENCES



ERIS LIFESCIENCES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF ERIS LIFESCIENCES

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.14
0
0
0.05
0.38
0.02
0
0.13
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF ERIS LIFESCIENCES

Pledged Promoter Shares
10.95 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF ERIS LIFESCIENCES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
13.29%
-15.43%
-33.85%
-21.51%
36.77%
24.84%
0.98%
29.53%
QtrlyTrend
2
Latest Qtr: Mar2024
Quarterly Result Analysis →


ERIS LIFESCIENCES related INDICES

BSE Indices1W1M1Y
S&P BSE 400 MIDSMALLCAP 3.1% 6.6% 57.7%
S&P BSE MIDSMALLCAP 3.1% 6.7% 62.1%
S&P BSE SMALL CAP 3.1% 5.6% 60.5%
S&P BSE 250 SMALLCAP 2.5% 4.4% 56.8%
S&P BSE ALLCAP 2.4% 4.2% 38.5%
NSE Indices1W1M1Y
NIFTY MID SMALL400 3% 6.4% 60.1%
NIFTY SMALLCAP250 2.7% 4.5% 63.1%
NIFTY500 MULTICAP 50:25:25 2.6% 4.7% 45.4%
NIFTY 500 2.4% 4.2% 37.7%

You may also like the below Video Courses


FAQ about ERIS LIFESCIENCES


Is ERIS LIFESCIENCES good for long term investment?

As on May 22,2024, the Fundamentals of ERIS LIFESCIENCES look Strong and hence it may be good for long term investment! See Financial Performance of ERIS LIFESCIENCES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ERIS LIFESCIENCES UnderValued or OverValued?

As on May 22,2024, ERIS LIFESCIENCES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of ERIS LIFESCIENCES ?

As on May 22,2024, the Intrinsic Value of ERIS LIFESCIENCES is Rs. 1,031.99 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 613.51
Fair Value [Median EV / Sales Model] : Rs. 1,031.99
Fair Value [Median Price / Sales Model] : Rs. 1,119.21
Estimated Median Fair Value of ERIS LIFESCIENCES : Rs. 1,031.99

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is ERIS LIFESCIENCES trading at a Premium or Discount?

As on May 22,2024, ERIS LIFESCIENCES is trading at a Discount of -12% based on the estimates of Median Intrinsic Value!